Daridorexant, Idorsia's dual orexin receptor antagonist, shows consistent efficacy across both insomnia- and nocturia-related endpoints in a placebo-controlled study in patients with chronic insomnia ...
Daphne Guinness called him the love of her life. Emmanuel Macron texts him late at night to strategise. He’s a regular ...
Daridorexant, Idorsia's dual orexin receptor antagonist, shows consistent efficacy across both insomnia- and nocturia-related endpoints in a placebo-controlled study in patients with chronic insomnia ...
2-Year U.S. Treasury Note Continuous Contract $103.516-0.035-0.03% 5-Year U.S. Treasury Note Continuous Contract $107.875-0.078-0.07% 10-Year U.S. Treasury Note Continuous Contract $110.828-0.109 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback